Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Bone Biologics Corporation
First Two Patients Treated in Pilot Clinical Study with Bone Biologics’ NB1 Bone Graft Device in Spine Fusion
June 20, 2024
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
BBLGW
Bone Biologics Announces Closing of $2.0 Million Public Offering
March 06, 2024
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
Bone Biologics Announces Pricing of $2.0 Million Public Offering
March 04, 2024
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
Bone Biologics Reports Progress With NB1 Clinical Program
March 01, 2024
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors
January 11, 2024
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
BBLGW
Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements
January 10, 2024
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
BBLGW
Bone Biologics Announces 1-for-8 Reverse Stock Split
December 18, 2023
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
BBLGW
Bone Biologics Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 20, 2023
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
Bone Biologics Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 16, 2023
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
Bone Biologics Prices $5.0 Million Underwritten Public Offering
June 14, 2023
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
Bone Biologics Effects 1-for-30 Reverse Stock Split
June 06, 2023
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
Bone Biologics Receives Human Research Ethics Committee Approval to Begin Pilot Clinical Trial with NB1 in Spinal Fusion Patients in Australia
April 11, 2023
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
Bone Biologics Advances Preparations for NB1 Pilot Clinical Trial with Engagement of Contract Research Organization
January 26, 2023
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
Bone Biologics CEO Issues Letter to Stockholders
October 25, 2022
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
Bone Biologics Announces Closing of $5,100,000 Underwritten Public Offering
October 12, 2022
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
CORRECTING and REPLACING Bone Biologics Prices $5,100,000 Underwritten Public Offering
October 07, 2022
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
Bone Biologics to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest
March 23, 2022
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
Bone Biologics to Present at the H.C. Wainwright BioConnect Virtual Conference
January 05, 2022
From
Bone Biologics Corporation
Via
Business Wire
Tickers
BBLG
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit